Barclays PLC — Major Shareholding Notification 2021

Jan 29, 2021

National Storage Mechanism | Additional information

Form 8.3 - WILLIS TOWERS WATSON PLC

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

	Name of person dealing (Note 1)	Barclays PLC.
	Company dealt in	WILLIS TOWERS WATSON PLC
	Class of relevant security to which the	ORD
	dealings being disclosed relate (Note 2)
	Date of dealing	28 January 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		2,383,173	1.85%	605,666	0.47%
(2)	Derivatives (other than options):
		273,127	0.21%	445,393	0.35%
(3)	Options and agreements to
	purchase/sell:	6,000	0.00%	6,000	0.00%
(4)	TOTAL:
		2,662,300	2.07%	1,057,059	0.82%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long			Short
	Number		(%)	Number		(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	1	209.3000 USD
Purchase	38	207.5094 USD
Purchase	40	207.2788 USD
Purchase	42	207.4385 USD
Purchase	50	208.6900 USD
Purchase	66	207.2590 USD
Purchase	69	207.2191 USD
Purchase	71	208.0553 USD
Purchase	75	207.4040 USD
Purchase	82	207.4714 USD
Purchase	90	207.1970 USD
Purchase	96	207.3006 USD
Purchase	100	206.1900 USD
Purchase	100	206.2000 USD
Purchase	100	206.9800 USD
Purchase	100	207.2000 USD
Purchase	100	207.2500 USD
Purchase	100	208.3400 USD
Purchase	100	208.4700 USD
Purchase	100	208.5000 USD
Purchase	100	208.5700 USD
Purchase	100	208.7750 USD
Purchase	100	208.7900 USD
Purchase	102	207.7994 USD
Purchase	118	207.2400 USD
Purchase	185	207.2700 USD
Purchase	200	206.2650 USD
Purchase	200	207.6900 USD
Purchase	205	206.3606 USD
Purchase	211	207.4905 USD
Purchase	268	207.3104 USD
Purchase	284	208.5630 USD
Purchase	383	208.2479 USD
Purchase	393	207.3125 USD
Purchase	808	207.2344 USD
Purchase	834	208.5514 USD
Purchase	959	207.0706 USD
Purchase	1,058	207.6593 USD
Purchase	1,123	207.6912 USD
Purchase	1,255	207.0778 USD
Purchase	1,621	206.7608 USD
Purchase	3,758	206.3100 USD
Purchase	3,804	206.3543 USD
Purchase	6,209	207.0068 USD
Purchase	6,999	207.1052 USD
Sale	2	206.0900 USD
Sale	2	208.5500 USD
Sale	7	207.3200 USD
Sale	10	207.3480 USD
Sale	33	207.2700 USD
Sale	100	206.2100 USD
Sale	100	207.4800 USD
Sale	174	206.4611 USD
Sale	183	208.1582 USD
Sale	200	207.6900 USD
Sale	206	207.6486 USD
Sale	218	208.2400 USD
Sale	219	207.3330 USD
Sale	250	207.2279 USD
Sale	665	206.3144 USD
Sale	834	208.5514 USD
Sale	834	208.5515 USD
Sale	917	207.7008 USD
Sale	948	207.3252 USD
Sale	1,008	207.2615 USD
Sale	1,123	207.6912 USD
Sale	1,262	207.0822 USD
Sale	1,355	207.0130 USD
Sale	2,985	206.3100 USD
Sale	3,315	206.3129 USD
Sale	7,204	206.9617 USD
Sale	8,139	207.1045 USD

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?	YES
Date of disclosure:	29 Jan 2021
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name	Written or	Number of	Exercise	Type	Expiry
	purchased	relevant securities	price		date
		to which the option
		or derivative
		relates
Call Options	Purchased	6,000	220.0000	American	Jul 16, 2021
Put Options	Purchased	-6,000	200.0000	American	Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210129005322/en/

BARCLAYS PLC